Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Twitter, Inc. (“Twitter” or the “Company”) (NYSE: TWTR). Such investors are advised to...
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pintec Technology Holdings Limited (“Pintec” or the “Company”) (NASDAQ: PT). Such...
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BeiGene, Ltd. (“BeiGene” or the “Company”) (NASDAQ: BGNE). Such investors are advised to...
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA). Such investors are advised to...
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First American Financial Corporation (“First American” or the “Company”) (NYSE: FAF). ...
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR). Such...
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of USA Technologies, Inc. (“USA Technologies” or the “Company”) (OTCMKTS: USAT). Such...
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Monolithic Power Systems, Inc. (“Monolithic” or the “Company”) (NASDAQ: MPWR). Such...
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cintas Corporation (“Cintas” or the “Company”) (NASDAQ: CTAS). Such investors are...
-
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AMAG Pharmaceuticals, Inc. (“AMAG” or the “Company”) (NASDAQ: AMAG). Such investors are...